arrow
G

Giuseppe Salemi

University of Palermo
H指数:46
被引数:7,436

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Validation of generative artificial intelligence techniques for synthetic data generation in multiple sclerosis research: A comparison with real-world evidence from the Italian multiple sclerosis registry

生成式人工智能技术在多发性硬化症研究中合成数据生成中的验证:与意大利多发性硬化症登记处真实世界证据的比较

2026-10-140
PRE
Effectiveness of Rituximab in rElapsiNg Multiple SclErosis previously treated with hiGhly-Active Disease modifying thErapies (RENEGADE study)

利妥昔单抗在高活性疾病修饰疗法治疗后的复发型多发性硬化中的有效性(RENEGADE研究)

2025-12-240
OAAI
Hypertension, Diabetes and Depression as Modifiable Risk Factors for Dementia: A Common Data Model Approach in a Population-Based Cohort, with Study Protocol and Preliminary Results

高血压、糖尿病和抑郁症作为痴呆的可改变危险因素:一项基于人群队列的常见数据模型方法,包括研究方案和初步结果

2025-10-010
OAAI
High-intensity interval training improves bone remodeling, lipid profile, and physical function in multiple sclerosis patients

高强度间歇训练可改善多发性硬化症患者的骨骼重塑,脂质分布和身体功能

2024-07-132
OAAI
Evaluation of core Biomarkers of Alzheimer's disease in saliva and plasma measured by chemiluminescent enzyme immunoassays on a fully automated platform

在全自动平台上通过化学发光酶免疫测定法评估唾液和血浆中阿尔茨海默病的核心生物标志物

2024-07-123
OAAI
Efficacy and Safety of Rescue Treatment with Plasma Exchange in Patients with Acute Inflammatory Neurological Disorders: A Single Center Experience

血浆置换作为急性炎症性神经系统疾病患者抢救治疗的有效性和安全性:单中心经验

2024-07-100
OAAI
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study

那他珠单抗治疗继发性进行性多发性硬化的长期疗效: 一项倾向匹配研究

2024-07-011
OAAI
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries

控制小儿多发性硬化症患者残疾恶化的疾病改善疗法: 全球和国家注册机构的纵向分析

2024-05-014
PRE
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience

在MS中使用那他珠单抗治疗的不同方案中的治疗调节剂: 意大利的真实世界经验

2024-04-011
OAAI